Cargando…
Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach
Using thyrotropin-releasing hormone (TRH) as a model, we explored whether synergistic combination of lipoamino acid(s) and a linker cleaved by prolyl oligopeptidase (POP) can be used as a promoiety for prodrug design for the preferential brain delivery of the peptide. A representative prodrug based...
Autores principales: | Prokai-Tatrai, Katalin, De La Cruz, Daniel L., Nguyen, Vien, Ross, Benjamin P., Toth, Istvan, Prokai, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680701/ https://www.ncbi.nlm.nih.gov/pubmed/31323784 http://dx.doi.org/10.3390/pharmaceutics11070349 |
Ejemplares similares
-
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2013) -
Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2009) -
[β-Glu(2)]TRH Is a Functional Antagonist of Thyrotropin-Releasing Hormone (TRH) in the Rodent Brain
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2021) -
The Antagonist pGlu-βGlu-Pro-NH(2) Binds to an Allosteric Site of the Thyrotropin-Releasing Hormone Receptor
por: De La Cruz, Daniel L., et al.
Publicado: (2021) -
Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the periphery
por: Merchenthaler, Istvan, et al.
Publicado: (2016)